Beauty Farm Medical & Health Industry (FRA:XC5) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Beauty Farm Medical & Health Industry EBITDA Margin % Related Terms
Beauty Farm Medical & Health Industry EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beauty Farm Medical & Health Industry EBITDA Margin % Chart
FRA:XC5 vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Beauty Farm Medical & Health Industry's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beauty Farm Medical & Health Industry EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Beauty Farm Medical & Health Industry's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Beauty Farm Medical & Health Industry's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beauty Farm Medical & Health Industry (FRA:XC5) has a EBITDA Margin % of 17.26% as of Dec. 2025. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beauty Farm Medical & Health Industry and its competitors. This is 43% below median its historical median of 30.06. Over the past decade, Beauty Farm Medical & Health Industry's EBITDA Margin % has ranged from 17.56 to 31.51. According to the industry distribution chart, Beauty Farm Medical & Health Industry ranks #210 out of 668 companies in the Healthcare Providers & Services industry, placing it in the top 31.4%.
Is Beauty Farm Medical & Health Industry's EBITDA Margin % too high?
Beauty Farm Medical & Health Industry's current EBITDA Margin % of 17.26% is 43% below median its 10-year median of 30.06. Over the past 10 years, this metric has ranged from a low of 17.56 to a high of 31.51. The Healthcare Providers & Services industry median EBITDA Margin % is 10.21. Beauty Farm Medical & Health Industry's value of 17.26% is 69% above this industry median. Based on the distribution chart, Beauty Farm Medical & Health Industry ranks #210 out of 668 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Beauty Farm Medical & Health Industry has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Beauty Farm Medical & Health Industry's EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Beauty Farm Medical & Health Industry ranks #210 out of 668 companies for EBITDA Margin %. This puts Beauty Farm Medical & Health Industry in the upper half of its industry. The industry median EBITDA Margin % is 10.21. Beauty Farm Medical & Health Industry's value of 17.26% is 69% above this benchmark. Historically, Beauty Farm Medical & Health Industry's own EBITDA Margin % has ranged from 17.56 to 31.51 over the past decade. While the company's 10-year median is 30.06 vs. the industry median of 10.21, Beauty Farm Medical & Health Industry has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.21, based on 668 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beauty Farm Medical & Health Industry's current EBITDA Margin % of 17.26% is 69% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Beauty Farm Medical & Health Industry and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beauty Farm Medical & Health Industry's current EBITDA Margin % is 17.26%, which is 43% below median its own 10-year median of 30.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beauty Farm Medical & Health Industry stock overvalued right now?
Beauty Farm Medical & Health Industry (FRA:XC5) has a current EBITDA Margin % of 17.26%. The stock's GF Value™ is €2.96, compared to a current price of €1.67 — trading 43.6% below its estimated fair value. The current EBITDA Margin % is 17.26%, which is 43% below median its 10-year median of 30.06 and 69% above the Healthcare Providers & Services industry median of 10.21. Beauty Farm Medical & Health Industry's overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Beauty Farm Medical & Health Industry (FRA:XC5), the current EBITDA Margin % is 17.26% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beauty Farm Medical & Health Industry (FRA:XC5) Overvalued in 2026?
Based on GuruFocus' analysis, Beauty Farm Medical & Health Industry stock appears to be undervalued.
The current stock price of €1.67 is trading 43.6% below its estimated GF Value™ of €2.96.
Key valuation signals for FRA:XC5:
EBITDA Margin %: 17.26% (43% below median its 10-year median of 30.06)
GF Value™: €2.96 vs. price of €1.67 (43.6% below fair value)
Industry Position: 69% above the Healthcare Providers & Services median (#210 of 668)
No single metric tells the full story. See the FRA:XC5 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beauty Farm Medical & Health Industry Business Description
Beauty Farm Medical & Health Industry Inc. provides beauty and wellness services in the People's Republic of China. It offers high-quality beauty and wellness services, aesthetic medical services, and subhealth medical services according to customers' individual needs. The company offers its products and services through brands such as Beauty Farm, Palaispa, Naturade, Cellcare, and Neology.
85GF Score
Get the complete analysis for FRA:XC5
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:XC5 has been successfully added to your 
